These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 11234292)
1. [Progress in the field of medical devices for diabetes]. Peters-Volleberg GW; Hilbers-Modderman ES; van den Berg Jeths A Ned Tijdschr Geneeskd; 2001 Feb; 145(7):307-10. PubMed ID: 11234292 [TBL] [Abstract][Full Text] [Related]
2. Real-time glucose sensors in children and adolescents with type-1 diabetes. Danne T; Lange K; Kordonouri O Horm Res; 2008; 70(4):193-202. PubMed ID: 18772591 [TBL] [Abstract][Full Text] [Related]
3. Simulation based cost-benefit analysis of a telemedical system for closed-loop insulin pump therapy of diabetes. Bott OJ; Hoffmann I; Bergmann J; Kosche P; von Ahn C; Mattfeld DC; Schnell O; Pretschner DP Stud Health Technol Inform; 2006; 124():435-40. PubMed ID: 17108558 [TBL] [Abstract][Full Text] [Related]
4. Trends in the prescription and cost of diabetic medications and monitoring equipment in England 1991-2004. Patel H; Srishanmuganathan J; Car J; Majeed A J Public Health (Oxf); 2007 Mar; 29(1):48-52. PubMed ID: 17124257 [TBL] [Abstract][Full Text] [Related]
5. [From external to implantable insulin pump, can we close the loop?]. Renard E; Costalat G; Bringer J Diabetes Metab; 2002 Sep; 28(4 Pt 2):2S19-2S25. PubMed ID: 12442060 [TBL] [Abstract][Full Text] [Related]
6. Home monitoring of glucose and blood pressure. Taylor JR; Campbell KM Am Fam Physician; 2007 Jul; 76(2):255-60. PubMed ID: 17695570 [TBL] [Abstract][Full Text] [Related]
7. Glucose sensors: toward closed loop insulin delivery. Chia CW; Saudek CD Endocrinol Metab Clin North Am; 2004 Mar; 33(1):175-95, xi. PubMed ID: 15053902 [No Abstract] [Full Text] [Related]
8. The artificial pancreas: how close are we to closing the loop? Clarke WL; Kovatchev B Pediatr Endocrinol Rev; 2007 Jun; 4(4):314-6. PubMed ID: 17643078 [No Abstract] [Full Text] [Related]
9. Continuous glucose monitoring: an overview of today's technologies and their clinical applications. Heinemann L; Koschinsky T Int J Clin Pract Suppl; 2002 Jul; (129):75-9. PubMed ID: 12166611 [TBL] [Abstract][Full Text] [Related]
10. [The status and outlook of treatment for diabetes mellitus]. Efimov AS; Skrobonskaia NA; Karabun PM; Danilova AI; Zubkova ST; Naumenko VG; Sakalo EA; Tkachuk IuV; Kostiuk EP; Mel'nik IM Klin Med (Mosk); 1990 Oct; 68(10):17-23. PubMed ID: 2077271 [No Abstract] [Full Text] [Related]
11. [Insulin therapy by insulin pump: continuous or conventional self-blood glucose monitoring? ]. Renard E Diabetes Metab; 2003 Apr; 29(2 Pt 2):S54-62. PubMed ID: 12746628 [TBL] [Abstract][Full Text] [Related]
14. Islet transplantation: a realistic alternative for the treatment of insulin deficient diabetes mellitus. Kim KW Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S11-7. PubMed ID: 15563959 [TBL] [Abstract][Full Text] [Related]
15. Implantable glucose sensors: present status and future developments. Kerner W Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S341-6. PubMed ID: 11460582 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic islet and stem cell transplantation: new strategies in cell therapy of diabetes mellitus. Bretzel RG; Eckhard M; Brendel MD Panminerva Med; 2004 Mar; 46(1):25-42. PubMed ID: 15238879 [TBL] [Abstract][Full Text] [Related]
17. Nanomedicine and its potential in diabetes research and practice. Pickup JC; Zhi ZL; Khan F; Saxl T; Birch DJ Diabetes Metab Res Rev; 2008; 24(8):604-10. PubMed ID: 18802934 [TBL] [Abstract][Full Text] [Related]
18. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus. Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282 [TBL] [Abstract][Full Text] [Related]
19. [Recent progress in biosensors: problems awaiting solutions for long-term clinical applications of glucose sensor]. Shichiri M; Fukushima H; Sakakida M; Kajiwara K Nihon Rinsho; 1991 Feb; 49 Suppl():553-62. PubMed ID: 2033850 [No Abstract] [Full Text] [Related]
20. HIS modelling and simulation based cost-benefit analysis of a telemedical system for closed-loop diabetes therapy. Bott OJ; Hoffmann I; Bergmann J; Gusew N; Schnell O; Gómez EJ; Hernando ME; Kosche P; von Ahn C; Mattfeld DC; Pretschner DP Int J Med Inform; 2007 Dec; 76 Suppl 3():S447-55. PubMed ID: 17656150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]